SCHEMBL6137921

SCHEMBL6137921

COc1ccc(C(=O)N(CC(C)Oc2ccccc2)C(=N)N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 2/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
HTT P42858 1/20 0.40
LPAR1 Q92633 1/20 0.40
LPAR5 Q9H1C0 1/20 0.40
TRPM8 Q7Z2W7 2/20 0.40
PRSS1 P07477 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137828 0.79 ACHE (0.56) KDM4EHPGDALDH1A1HTTLPAR1
SCHEMBL6137598 0.78 DRD2 (0.53) KDM4EHPGDALDH1A1DRD2DRD3
SCHEMBL6003647 0.74 LPAR1 (0.53) KDM4EHPGDALDH1A1HTTLPAR1
SCHEMBL4627482 0.73 SCN2A (0.59) KDM4EALDH1A1CRHBPCRHR2HTT
SCHEMBL6137845 0.71 L3MBTL1 (0.52) KDM4EHPGDMTNR1AALDH1A1PARP10
SCHEMBL6138031 0.71 CA1 (0.45) KDM4EHPGDCES2CES1ALDH1A1
Hydrochloric Acid SCHEMBL8767719 0.71 CA1 (0.45) KDM4EHPGDCES2CES1DRD2
SCHEMBL28183213 0.67 CES2 (0.65) KDM4EHPGDCES2CES1ALDH1A1
SCHEMBL6137840 0.67 SCN5A (0.49) PRSS1PRSS2PRSS3PARP10NPC1
Anisole SCHEMBL27279235 0.66 CA4 (0.58) CES2CES1ALDH1A1HTTPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed